HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Molecular analysis of patients with severe congenital factor X deficiency: First report from north and northwest of Iran.

Abstract
Background Congenital FX deficiency is an extremely rare autosomal recessive disorder, mostly present in regions with a high rate of consanguinity, with an incidence of approximately 1:2,000,000 in the general population. The aim of this study was to evaluate the clinical manifestations and to provide a molecular analysis of 14 patients with homozygous factor X deficiency. Methods We evaluated the results of clinical and molecular characterization of 14 new cases (10 males, 4 females aged from 4 to 17 years) of FXD (FX activity <1%) in North and Northwest of Iran. FXD was diagnosed by clinical findings and routine laboratory tests. The PCR products of all the eight exons and their intron-exon boundaries were sequenced using DNA sequencer. Results Mean age of patients and mean age at diagnosis were 9 and 2.5 years, respectively. The molecular analysis revealed five different mutations, all of them were previously described. Molecular analysis showed five different homozygous and double heterozygous mutations including Arg-1Thr, Cys81Tyr, Gly78Asp, IVS1+3, and IVS2-3. Discussion The study of a large population of factor X patients from three institutions indicated that FXD was one of the most serious among rare bleeding disorders and that factor X gene mutation may be related to bleeding tendency in patients.
AuthorsSaeid Morovvati, Reza Ranjbar, Mohammadreza Younesi
JournalHematology (Amsterdam, Netherlands) (Hematology) Pg. (May 18 2015) ISSN: 1607-8454 [Electronic] England
PMID25984924 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: